| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000006165 |
| Receipt No. | R000007286 |
| Scientific Title | Assessment of maggot debridement therapy for leg ulcer |
| Date of disclosure of the study information | 2011/08/15 |
| Last modified on | 2019/03/16 (Ver. 3) |
| Basic information | ||
| Public title | Assessment of maggot debridement therapy for leg ulcer | |
| Acronym | Assessment of maggot debridement therapy for leg ulcer | |
| Scientific Title | Assessment of maggot debridement therapy for leg ulcer | |
| Scientific Title:Acronym | Assessment of maggot debridement therapy for leg ulcer | |
| Region |
|
|
| Condition | ||
| Condition | Leg ulcer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Assessment of prognosis and efficacy for maggot debridement therapy |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase I,II |
| Assessment | |
| Primary outcomes | Impact of maggot debridement therapy for severity and prognosis of leg ulcer |
| Key secondary outcomes | Clinical parameter in response to maggot debridement therapy |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Maggot debridement therapy: 48hr | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient with leg ulcer | |||
| Key exclusion criteria | 1) no evidence of leg ulcer, 2) unable to obtain informed consent, 3) smoker unable to quit smoking, 4) drug addiction of any kind (including alcohol), 5) complication of any serious disease affecting the patient's general condition | |||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Nippon Medical School | ||||||
| Division name | Department of Cardiovascular Medicine | ||||||
| Zip code | 113 8603 | ||||||
| Address | 1-1-5, Sendagi, Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3822-2131 | ||||||
| gen52@nms.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Nippon Medical School | ||||||
| Division name | Department of Cardiovascular Medicine | ||||||
| Zip code | 113 8603 | ||||||
| Address | 1-1-5, Sendagi, Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3822-2131 | ||||||
| Homepage URL | |||||||
| miyamoto-m@nms.ac.jp | |||||||
| Sponsor | |
| Institute | Nippon Medical School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Cardiovascular Medicine, Nippon Medical School |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | IRB-Nippon Medical School |
| Address | 1-1-5, Sendagi, Bunkyo-ku, Tokyo |
| Tel | 0338222131 |
| clinicaltrial@nms.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 日本医科大学付属病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000007286 |